- [1]
-
C. Dimitrakakis, J. Zhou, C.A. BondyAndrogens and mammary growth and neoplasia
Fertility and Sterility, 77 (2002), pp. 26-33
- [2]
-
U.J. SalmonEffect of testosterone propionate upon gonadotropic hormone excretion and vaginal smears of human female castrate
Proceedings of the Society for Experimental Biology and Medicine, Society for Experimental Biology and Medicine (New York, NY), 3 (1937), pp. 488-491
- [3]
-
H. Takeda, G. Chodak, S. Mutchnik, T. Nakamoto, C. ChangImmunohistochemical localization of androgen receptors with mono-and polyclonal antibodies to androgen receptor
Journal of Endocrinology, 126 (1990), pp. 17-25
- [4]
-
C.M. Wilson, M.J. McPhaulA and B forms of the androgen receptor are expressed in a variety of human tissues
Molecular and Cellular Endocrinology, 120 (1996), pp. 51-57
- [5]
-
R. Glaser, A.E. York, C. DimitrakakisBeneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)
Maturitas, 68 (2011), pp. 355-361
- [6]
-
K. Maclaran, N. PanayThe safety of postmenopausal testosterone therapy
Womens Health, 8 (2012), pp. 263-275
- [7]
-
D.A. DaveyAndrogens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy
Womens Health, 8 (2012), pp. 437-446
- [8]
-
A.A. LoeserMale hormone in gynaecology and obstetrics and in cancer of the female breast
Obstetrical & Gynecological Survey, 3 (1948), pp. 363-381
- [9]
-
R. Glaser, S. Kalantaridou, C. DimitrakakisTestosterone implants in women: pharmacological dosing for a physiologic effect
Maturitas, 74 (2013), pp. 179-184
- [10]
-
R.L. Glaser, C. Dimitrakakis, A.G. MessengerImprovement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study
British Journal of Dermatology, 166 (2012), pp. 274-278
- [11]
-
P.J. BrunskillThe effects of fetal exposure to danazol
BJOG: An International Journal of Obstetrics and Gynaecology, 99 (1992), pp. 212-215
- [12]
-
M.F. TarttelinEarly prenatal treatment of ewes with testosterone completely masculinises external genitalia of female offspring but has no effects on early body weight changes
Acta Endocrinologica, 113 (1986), pp. 153-160
- [13]
-
C.J. Wolf, A. Hotchkiss, J.S. Ostby, G.A. LeBlanc, L.E. GrayEffects of prenatal testosterone propionate on the sexual development of male and female rats: a dose–response study
Toxicological Sciences, 65 (2002), pp. 71-86
- [14]
-
A.K. Hotchkiss, C.S. Lambright, J.S. Ostby, L. Parks-Saldutti, J.G. Vandenbergh, L.E. GrayPrenatal testosterone exposure permanently masculinizes anogenital distance, nipple development, and reproductive tract morphology in female Sprague-Dawley rats
Toxicological Sciences, 96 (2007), pp. 335-345
- [15]
-
M. Mizuno, J. Lobotsky, C.W. Lloyd, T. Kobayashi, Y. MurasawaPlasma androstenedione and testosterone during pregnancy and in the newborn
Journal of Clinical Endocrinology & Metabolism, 28 (1968), pp. 1133-1142
- [16]
-
M.R. Syme, J.W. Paxton, J.A. KeelanDrug transfer and metabolism by the human placenta
Clinical Pharmacokinetics, 43 (2004), pp. 487-514
- [17]
-
S.R. Schwartz, S.M. Cohen, S.H. Dailey, et al.Clinical practice guideline: hoarseness (dysphonia)
Otolaryngology-Head and Neck Surgery, 141 (2009), pp. S1-S31
- [18]
-
M.A. Pattie, B.E. Murdoch, D. Theodoros, K. ForbesVoice changes in women treated for endometriosis and related conditions: the need for comprehensive vocal assessment
Journal of Voice, 12 (1998), pp. 366-371
- [19]
-
F. Nordenskjöld, S. FexVocal effects of danazol therapy
Acta Obstetricia et Gynecologica Scandinavica, 63 (1984), pp. 131-132
- [20]
-
S. Arias-Santiago, M.T. Gutiérrez-Salmerón, L. Castellote-Caballero, A. Buendía-Eisman, R. Naranjo-SintesAndrogenetic alopecia and cardiovascular risk factors in men and women: a comparative study
Journal of the American Academy of Dermatology, 63 (2010), pp. 420-429
- [21]
-
V. Matilainen, M. Laakso, P. Hirsso, P. Koskela, U. Rajala, S. Keinänen-KiukaanniemiHair loss, insulin resistance, and heredity in middle-aged women. A population-based study
European Journal of Cardiovascular Risk, 10 (2003), pp. 227-231
- [22]
-
J.W. Tomlinson, J. Finney, B.A. Hughes, S.V. Hughes, P.M. StewartReduced glucocorticoid production rate, decreased 5α-reductase activity, and adipose tissue insulin sensitization after weight loss
Diabetes, 57 (2008), pp. 1536-1543
- [23]
-
T.H. Jones, F. SaadThe effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Atherosclerosis, 207 (2009), p. 318
- [24]
-
J. Møller, H. EinfeldtTestosterone treatment of cardiovascular diseases: principles and clinical experience
Springer-Verlag (1984)
- [25]
-
G.M.C. Rosano, F. Leonardo, P. Pagnotta, et al.Acute anti-ischemic effect of testosterone in men with coronary artery disease
Circulation, 99 (1999), pp. 1666-1670
- [26]
-
S. Worboys, D. Kotsopoulos, H. Teede, B. McGrath, S.R. DavisEvidence that parenteral testosterone therapy may improve endothelium-dependent and-independent vasodilation in postmenopausal women already receiving estrogen
Journal of Clinical Endocrinology & Metabolism, 86 (2001), pp. 158-161
- [27]
-
C.J. Malkin, P.J. Pugh, J.N. West, E.J.R. van Beek, T.H. Jones, K.S. ChannerTestosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
European Heart Journal, 27 (2006), pp. 57-64
- [28]
-
C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, K.S. ChannerLow serum testosterone and increased mortality in men with coronary heart disease
Heart, 96 (2010), pp. 1821-1825
- [29]
-
G.A. Laughlin, E. Barrett-Connor, J. BergstromLow serum testosterone and mortality in older men
Journal of Clinical Endocrinology & Metabolism, 93 (2008), pp. 68-75
- [30]
-
F. Iellamo, M. Volterrani, G. Caminiti, et al.Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study
Journal of the American College of Cardiology, 56 (2010), pp. 1310-1316
- [31]
-
D.J. Handelsman, A.J. Conway, C.J. Howe, L. Turner, M.A. MackeyEstablishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot
Journal of Clinical Endocrinology & Metabolism, 81 (1996), pp. 4113-4121
- [32]
-
D.B. O’Connor, J. Archer, F.C.W. WuEffects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study
Journal of Clinical Endocrinology & Metabolism, 89 (2004), pp. 2837-2845
- [33]
-
B.C. Trainor, H.H. Kyomen, C.A. MarlerEstrogenic encounters: how interactions between aromatase and the environment modulate aggression
Frontiers in Neuroendocrinology, 27 (2006), pp. 170-179
- [34]
-
M. Giammanco, G. Tabacchi, S. Giammanco, D. Di Majo, M. La GuardiaTestosterone and aggressiveness
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 11 (2005), p. RA136
- [35]
-
T.E. Hickey, J.L.L. Robinson, J.S. Carroll, W.D. TilleyMinireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor oncogene?
Molecular Endocrinology, 26 (2012), pp. 1252-1267
- [36]
-
N. Eigėlienė, T. Elo, M. Linhala, S. Hurme, R. Erkkola, P. HärkönenAndrogens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures
Journal of Clinical Endocrinology & Metabolism, 97 (2012), pp. E1116-E1127
- [37]
-
M. Hofling, A.L. Hirschberg, L. Skoog, E. Tani, T. Hägerström, B. von SchoultzTestosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women
Menopause, 14 (2007), pp. 183-190
- [38]
-
C. Dimitrakakis, J. Zhou, J. Wang, et al.A physiologic role for testosterone in limiting estrogenic stimulation of the breast
Menopause, 10 (2003), pp. 292-298
- [39]
-
C. Dimitrakakis, R.A. Jones, A. Liu, C.A. BondyBreast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy
Menopause, 11 (2004), pp. 531-535
- [40]
-
R. GlaserSubcutaneous testosterone-anastrozole implant therapy in breast cancer survivors
American society of clinical oncology breast cancer symposium (2010)
- [41]
- A221102, Randomized Double-Blind Placebo Controlled Study of Subcutaneous Testosterone in the Adjuvant Treatment of Postmenopausal Women with Aromatase Inhibitor Induced Arthralgias.
- [42]
-
R.D. GambrellJr, P.K. NatrajanModerate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports
Climacteric, 9 (2006), pp. 224-233
- [43]
-
A.M. Traish, L.J. GoorenSafety of physiological testosterone therapy in women: lessons from female to male transsexuals (FMT) treated with pharmacological testosterone therapy
The Journal of Sexual Medicine, 7 (2010), pp. 3758-3764
- [44]
-
T.P. Van Staa, J.M. SprafkaStudy of adverse outcomes in women using testosterone therapy
Maturitas, 62 (2009), pp. 76-80